Skip to main content
Premium Trial:

Request an Annual Quote

BioTek, Gyrasol Ink Co-marketing Pact

NEW YORK (GenomeWeb News) – BioTek Instruments has struck a co-marketing agreement with the specialty assay developer Gyrasol, under which the companies will jointly promote an assay platform with a microplate reader, BioTek said today.
Under the agreement, the companies will promote the Gyrasol Sensor, a fluorescence-based assay platform, on BioTek’s Synergy 4 Hybrid microplate reader.
The Gyrasol Sensor is used in screening for kinases and phosphatases in a homogeneous format, and the BioTek microplate reader combines filter-based and monochromator-based fluorescence detection in one unit, BioTek said. The Synergy microplate reader offers multi-detection for “an unlimited number of current and future microplate-based assays,” the company said.
Further terms of the alliance were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.